Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Levy

Vascular & Interventional Radiology Atlanta, GA Medical Doctor

NPI 1316911126 CMS profile 241368

1000 Johnson Ferry Rd Ne, Atlanta, GA 30342

Open in the dashboard

General payments

$822,365

988 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$67,948 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Jason Levy of Atlanta, GA is reported in the CMS Open Payments database as having received $822,365 across 988 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $67,948 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $98,257 104
2024 General $162,890 170
2023 General $89,510 159
2022 General $136,431 163
2021 General $78,099 92
2020 General $88,065 79
2019 General $169,114 221

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Levy
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Jason Levy were reported at $98,257. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Jason Levy Vascular & Interventional Radiology median Middle half National median
2019 $169,114 $422 $125–$1,555 $163
2020 $88,065 $200 $68–$652 $114
2021 $78,099 $280 $99–$866 $132
2022 $136,431 $433 $137–$1,497 $149
2023 $89,510 $506 $152–$2,019 $160
2024 $162,890 $556 $175–$1,930 $164
2025 $98,257 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $350,392 370 payments
  2. Medtronic USA, Inc. $253,832 254 payments
  3. Stryker Corporation $174,674 133 payments
  4. Boston Scientific Corporation $20,569 37 payments
  5. Sirtex Medical Inc $12,449 82 payments
  6. Penumbra, Inc. $2,238 20 payments
  7. Galil Medical Inc. $1,500 1 payment
  8. AstraZeneca Pharmaceuticals LP $1,279 1 payment
  9. Siemens Medical Solutions USA, Inc. $1,016 14 payments
  10. Varian Medical Systems, Inc. $915 4 payments
  11. Other $3,501 72 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $472,565 135 payments
  2. Consulting Fee $205,315 53 payments
  3. Travel and Lodging $108,135 302 payments
  4. Food and Beverage $29,232 494 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $3,333 1 payment
  6. Grant $2,285 2 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,500 1 payment
Products named General payments · program years 2019–2025
  1. OSTEOCOOL RF ABLATION SYSTEM $180,163 195 payments
  2. OSTEOCOOL RF ABLATION Neuro Pain (includes Interventional) $156,974 157 payments
  3. KYPHON EXPRESS II KYPHOPAK TRAY $88,909 91 payments
  4. KYPHON Balloon Kyphoplasty Neuro Pain (includes Interventional) $88,557 90 payments
  5. OPTABLATE $74,759 35 payments
  6. SPINEJACK Interventional Spine $52,779 55 payments
  7. SPINEJACK Spine $34,759 12 payments
  8. KYPHON Balloon Kyphoplasty Neuro Pain (includes Interventional) $30,560 27 payments
  9. OSTEOCOOL RF ABLATION Neuro Pain (includes Interventional) $30,213 24 payments
  10. OMNICURVE $21,006 10 payments
  11. Other $106,507 295 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

101

Median for Diagnostic Radiology: 24

Drug cost

$376

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ondansetron Hcl Generic 27 $130
Methylprednisolone Generic 21 $120
Oxycodone Hcl Generic 24 $54
Pantoprazole Sodium Generic 14 $44
Famotidine Generic 15 $28

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 127 billing codes

Paid by Medicare

$136,428

Medicare's payments for the services billed

Medicare patients

583

Average age 75

Services billed

1,494

283 women, 300 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Ischemic heart disease 43%
Cancer 35%
Diabetes 32%
Chronic kidney disease 31%
Depression 28%
Heart failure 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

988 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record